News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-11-14 1:31:54 pm Acurx Pharmaceuticals, Inc. (ACXP) Q3 2023 Earnings Call Transcript SeekingAlpha
2023-11-14 4:1:0 am Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update PR Newswire
2023-11-09 5:52:7 am 12 Best Day Trading Stocks To Buy Insider Monkey
2023-11-02 4:1:0 am Acurx Announces Positive Top-Line Ibezapolstat Phase 2 Efficacy Results with 96% Clinical Cure Rate in Patients with C. difficile Infection PR Newswire
2023-10-25 4:1:0 am Acurx Pharmaceuticals to Discuss Third Quarter 2023 Financial Results and Provide Business Update PR Newswire
2023-10-20 7:43:0 am New to The Street Announces Six Business Interviews on its 524th Show, Airing on the Fox Business Network, Monday, October 23, 2023, at 10:30 PM PT GlobeNewswire
2023-10-19 4:1:0 am Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences PR Newswire
2023-10-08 7:0:59 am Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation Simply Wall St.
2023-10-02 4:1:0 am Acurx Pharmaceuticals Announces Successful Completion and Early Discontinuation of the Ibezapolstat Phase 2b Trial for Treatment of C. difficile Infection PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information